132 related articles for article (PubMed ID: 1384935)
1. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
Hashimoto K; Maeda H; Goromaru T
Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
[TBL] [Abstract][Full Text] [Related]
2. Effects of benzylpiperazine derivatives on the acute effects of 3,4-methylenedioxymethamphetamine in rat brain.
Hashimoto K
Neurosci Lett; 1993 Apr; 152(1-2):17-20. PubMed ID: 7685864
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.
Hashimoto K; Maeda H; Goromaru T
Eur J Pharmacol; 1992 Sep; 228(2-3):171-4. PubMed ID: 1280228
[TBL] [Abstract][Full Text] [Related]
4. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine.
Hashimoto K; Goromaru T
Fundam Clin Pharmacol; 1990; 4(6):635-41. PubMed ID: 1710592
[TBL] [Abstract][Full Text] [Related]
5. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
6. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
McKenna DJ; Peroutka SJ
J Neurochem; 1990 Jan; 54(1):14-22. PubMed ID: 1967141
[No Abstract] [Full Text] [Related]
7. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
Hekmatpanah CR; McKenna DJ; Peroutka SJ
Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011
[TBL] [Abstract][Full Text] [Related]
8. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of MDMA: neurochemical effects.
Schmidt CJ; Kehne JH
Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
[No Abstract] [Full Text] [Related]
10. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
Battaglia G; Yeh SY; De Souza EB
Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
[TBL] [Abstract][Full Text] [Related]
11. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
Kleven MS; Woolverton WL; Seiden LS
Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
Brodkin J; Malyala A; Nash JF
Pharmacol Biochem Behav; 1993 Jul; 45(3):647-53. PubMed ID: 8101380
[TBL] [Abstract][Full Text] [Related]
14. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Lehmann J; DeSouza EB; Culp S; Zaczek R
Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
[No Abstract] [Full Text] [Related]
15. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
16. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
Grob C; Bravo G; Walsh R
Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
[No Abstract] [Full Text] [Related]
17. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
Hekmatpanah CR; Peroutka SJ
Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
[TBL] [Abstract][Full Text] [Related]
18. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
19. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
Schmidt CJ; Wu L; Lovenberg W
Eur J Pharmacol; 1986 May; 124(1-2):175-8. PubMed ID: 2424776
[TBL] [Abstract][Full Text] [Related]
20. Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats.
Champney TH; Matthews RT
J Pineal Res; 1991; 11(3-4):163-7. PubMed ID: 1724461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
